Patents Assigned to Medtronic
-
Patent number: 12171438Abstract: A recapturable external LAA exclusion clip system includes a clip comprising first and second clip struts, at least one of the struts having a connector interface comprising a first portion of a lock, and a delivery device comprising a handle and an end effector. The handle comprises jaw and lock controls. The end effector is connected to the handle and comprises a clevis and first and second jaws. The jaws are connected to the clevis and operatively connected to the jaw control to actively articulate at least one of the jaws with respect to the other. At least one of the jaws has a connector comprising a second portion of the lock operatively connected to the lock control to removably lock with the first portion of the lock. The first and second portions of the lock have a locked state and are configured to unlock the locked state upon actuation of the lock control.Type: GrantFiled: October 19, 2023Date of Patent: December 24, 2024Assignee: Medtronic, Inc.Inventors: Derek Dee Deville, Matthew A. Palmer, Richard Cartledge, Thomas O. Bales, Jr., M. Sean McBrayer, William T. Bales, Michael Walter Kirk, William Ragheb, Eric Petersen, Carlos Rivera, Vincent Turturro
-
Patent number: 12172004Abstract: Methods and systems for positioning a leadless pacing device (LPD) in cardiac tissue are disclosed. A delivery device is employed that comprises a proximal end, a distal end and a lumen therebetween sized to receive the LPD. The LPD has a leadlet extending therefrom that includes a means to fixate the leadlet to tissue. The delivery device comprises an introducer to introduce the LPD into the lumen of the delivery device. The LPD is loaded in the distal end of the lumen of the delivery device. The leadlet extends proximally from the LPD while the fixation means extends distally toward the LPD. A LPD mover is configured to advance the LPD out of the delivery device. A leadlet mover is configured to advance the leadlet out of the lumen delivery device and cause the leadlet to engage with cardiac tissue.Type: GrantFiled: December 10, 2021Date of Patent: December 24, 2024Assignee: Medtronic, Inc.Inventors: Ronald A. Drake, Kenneth C. Gardeski, Carla Pfeiffer, Kevin R. Seifert, Lester O. Stener, Matthew D. Bonner
-
Patent number: 12171554Abstract: In some examples, a medical system includes a medical device. The medical device may include a housing configured to be implanted in a target site of a patient, a light emitter configured to emit a signal configured to cause a fluorescent marker to emit a fluoresced signal into the target site, and a light detector that may be configured to detect the fluoresced signal. The medical system may include processing circuitry configured to determine a characteristic of the fluorescent marker based on the emitted signal and the fluoresced signal. The characteristic of the fluorescent marker may be indicative of a presence of a compound in the patient, and the processing circuitry may be configured to track the presence of the compound of the patient based on the characteristic of the fluorescent marker.Type: GrantFiled: September 18, 2023Date of Patent: December 24, 2024Assignee: Medtronic, Inc.Inventors: John E. Burnes, James K. Carney, Jonathan L. Kuhn, Mark J. Phelps, Jesper Svenning Kristensen, Rodolphe Katra
-
Patent number: 12172010Abstract: A medical device is configured to deliver therapeutic electrical stimulation pulses by generating frequency modulated electrical stimulation pulse signals. The medical device includes a pulse signal source and a modulator. The pulse signal source generates an electrical stimulation pulse signal having a pulse width. The modulator may include a high frequency modulator configured to modulate a frequency of the pulse signal from a starting frequency down to a minimum frequency during the pulse width. The modulator may include a low frequency bias generator to modulate the offset of the pulse signal between a minimum offset and a maximum offset in other examples.Type: GrantFiled: May 26, 2023Date of Patent: December 24, 2024Assignee: Medtronic, Inc.Inventors: Vladimir P. Nikolski, Melissa G. T. Christie, Mark T. Marshall, Amy E. Thompson-Nauman
-
Publication number: 20240415639Abstract: Prosthetic valve devices for implantation within a body or lumen that are configured for hemodynamic monitoring. The prosthetic valve device includes one or more sensors in electrical communication with an inductor formed by a portion of the frame or coupled to the frame of the prosthetic valve device. The sensor is configured to measure a flow parameter within the prosthesis. The inductor is configured to relay a signal to an external detector, the signal being associated with the flow parameter measured by the sensor.Type: ApplicationFiled: March 5, 2024Publication date: December 19, 2024Applicant: Medtronic, Inc.Inventors: Zeyi GUAN, Geoffrey ORTH
-
Patent number: 12170352Abstract: Separator and electrolyte composites include a porous self-supporting separator film between or adjacent one or two electrolyte films. The electrolyte films may contain a glyme or mixture of glymes, LiX salt and complexing agent, such as PEO. The porous self-supporting separator film may be used dry or wetted with a liquid electrolyte composition. Solid state batteries and electrochemical cells are disclosed that include the described separator and electrolyte composites in combination with an anode and a cathode.Type: GrantFiled: August 11, 2022Date of Patent: December 17, 2024Assignee: Medtronic, Inc.Inventors: Hui Ye, Timothy T. Bomstad, Parthasarathy M. Gomadam, Gaurav Jain, Christian S. Nielsen, Prabhakar A. Tamirisa, Collette M. Vanelzen
-
Patent number: 12170388Abstract: A battery for an implantable medical device (IMD) configured to support a relatively high rate of energy discharge relative to its capacity to support energy intensive therapy delivery, such as high energy anti-tachyarrhythmia shocks, by the IMD. The battery includes a first electrode, a second electrode separated a distance from the first electrode, an electrolyte disposed between the first electrode and the second electrode. The electrolyte includes a lithium salt including LiAsF6, an organic solvent, and an electrolyte additive that includes vinylene carbonate.Type: GrantFiled: February 19, 2020Date of Patent: December 17, 2024Assignee: Medtronic, Inc.Inventor: Joachim Hossick-Schott
-
Patent number: 12168086Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate formed from a first material and a second material. At least one of the first and second materials includes a hemostatic agent. Kits, systems and methods are disclosed.Type: GrantFiled: February 11, 2021Date of Patent: December 17, 2024Assignee: Medtronic, IncInventors: Satish Pulapura, Fatima Buevich, Jorie S. Soskin, Franklin R. Mansfield, Kai R. Worrell, Charlie Wood, Jorge Alberto Trevino Blanco, Narvel M. Brooks, III
-
Patent number: 12168131Abstract: Devices, systems, and techniques are described for selecting an evoked compound action potential (ECAP) growth curve based on a posture of a patient. The ECAP growth curve defines a relationship between a parameter defining delivery of stimulation pulses delivered to the patient and a parameter of an ECAP signal of a nerve of a patient elicited by a stimulation pulse. In one example, a medical device detects a posture of a patient and selects an ECAP growth curve corresponding to the detected posture. The medical device selects, based on the ECAP growth curve corresponding to the detected posture and a characteristic of a detected ECAP signal, a value for a parameter for defining delivery of the stimulation pulses to the patient and controls delivery of the stimulation pulses according to the selected value for the parameter.Type: GrantFiled: October 6, 2023Date of Patent: December 17, 2024Assignee: Medtronic, Inc.Inventors: David A. Dinsmoor, Christopher L. Pulliam, Hank T. Bink, Kristin N. Hageman
-
Patent number: 12168133Abstract: Devices, systems, and techniques are described for identifying stimulation parameter values based on electrical stimulation that induces dyskinesia for the patient. For example, a method may include controlling, by processing circuitry, a medical device to deliver electrical stimulation to a portion of a brain of a patient, receiving, by the processing circuitry, information representative of an electrical signal sensed from the brain after delivery of the electrical stimulation, determining, by the processing circuitry and from the information representative of the electrical signal, a peak in a spectral power of the electrical signal at a second frequency lower than a first frequency of the electrical stimulation, and responsive to determining the peak in the spectral power of the electrical signal at the second frequency, performing, by the processing circuitry, an action.Type: GrantFiled: April 10, 2023Date of Patent: December 17, 2024Assignee: Medtronic, Inc.Inventors: Rene A. Molina, Scott R. Stanslaski, Jadin C. Jackson, Christopher L Pulliam, Eric J. Panken, Michelle A. Case, Abbey Beuning Holt Becker
-
Patent number: 12167908Abstract: This disclosure is directed to devices, systems, and techniques for dynamically adjusting a bio impedance measurement range. An example device includes a plurality of electrodes. The device also includes sensing circuitry configured to sense a bio impedance and processing circuitry. The processing circuitry is configured to apply an excitation signal to the sensing circuitry and, based on the application of the excitation signal, determine a sensed bio impedance value within a bio impedance measurement range. The processing circuitry is also configured to determine whether the sensed bio impedance value is within a predetermined portion of the bio impedance measurement range for a predetermined period of time and based on the sensed bio impedance value being within the predetermined portion of the bio impedance measurement range for the predetermined period of time, adjust the excitation signal.Type: GrantFiled: July 20, 2021Date of Patent: December 17, 2024Assignee: Medtronic, Inc.Inventors: Hyun J. Yoon, Jon E. Thissen, Jerry D. Reiland, Ashley L Galarneau
-
Patent number: 12168085Abstract: A surgical system including an implantable medical device having a size and shape. The surgical device having a substrate and a coating that covers at least a portion of the substrate. The coating includes a polymer, collagen, glycerin and a hemostatic agent. The polymer is selected from the group of polyhydroxybutyrate, polyglycerol sebacate and adducts of polyglycerol sebacate. The substrate including a first piece and a second piece that is joined with the first piece. The first piece and the second piece forming a pocket having a cavity and an opening that is in communication with the cavity. The device being pre-formed such that a size and shape of the cavity conforms to the size and shape of the implantable medical device.Type: GrantFiled: May 3, 2021Date of Patent: December 17, 2024Assignee: Medtronic, IncInventors: Sean Chen, Kirsten R. Stark, Satish Pulapura, Kasyap V. Seethamraju, Jonathan T. Goodman, DanThanh H. Le
-
Patent number: 12161836Abstract: A flexible tubing for a cannula has a hollow tubing body having a length dimension from a first end to a second end, and an outer diameter of no more than 0.9 mm. The tubing body has a section of enhanced flexibility of a greater flexibility than one or more other sections of the tubing body. The section of enhanced flexibility is spaced from the first end of the tubing body by a distance D, where D is within a range of 3.0 mm to 5.0 mm for a flexible tubing having a length of about 9.0 mm, and where D is within a range of 1.0 mm to 2.9 mm for a flexible tubing having a length of about 6.0 mm.Type: GrantFiled: June 10, 2019Date of Patent: December 10, 2024Assignee: Medtronic MiniMed, Inc.Inventors: An Thien Pham, Matthew William Yavorsky, Amith Wijesuriya, Yevgeniy Levin
-
Patent number: 12161406Abstract: Devices and systems used to ablate tissue of a tumor using laser energy are disclosed. The devices and systems include a laser probe and a magnetic resonance (MR) safe temperature probe. The MR safe temperature probe includes an optical sensor. A bone anchor fixture separates the laser probe and the MR safe temperature probe to prevent interference in the MR safe temperature probe data. Proton Resonance Frequency (PRF) thermometry is used to model a temperature of a pixel of an MR image located adjacent the optical sensor. The modeled pixel temperature and the measured temperature are compared and monitored. Exceeding a threshold difference value causes an intervening action to occur.Type: GrantFiled: May 12, 2021Date of Patent: December 10, 2024Assignee: Medtronic Navigation, Inc.Inventors: Marco Capote, Emilio Esparza-Coss, Rebecca Vincelette, Katherine Lemley, Eric Baxter, Shawn Santana
-
Patent number: 12161487Abstract: Techniques are disclosed for monitoring a patient for the occurrence of cardiac arrhythmias. A computing system obtains a cardiac electrogram (EGM) strip for a current patient. Additionally, the computing system may apply a first cardiac rhythm classifier (CRC) with a segment of the cardiac EGM strip as input. The first CRC is trained on training cardiac EGM strips from a first population. The first CRC generates first data regarding an aspect of a cardiac rhythm of the current patient. The computing system may also apply a second CRC with the segment of the cardiac EGM strip as input. The second CRC is trained on training cardiac EGM strips from a smaller, second population. The second CRC generates second data regarding the aspect of the cardiac rhythm of the current patient. The computing system may generate output data based on the first and/or second data.Type: GrantFiled: April 21, 2023Date of Patent: December 10, 2024Assignee: Medtronic, Inc.Inventors: Niranjan Chakravarthy, Siddharth Dani, Tarek D. Haddad, Rodolphe Katra, Donald R. Musgrove, Lindsay A. Pedalty, Andrew Radtke
-
Patent number: 12161871Abstract: This disclosure relates to methods, devices, and systems for delivering and adjusting stimulation therapy. In one example, a method comprising delivering, by a stimulation electrode, electrical stimulation as a candidate therapy to a patient according to a set of candidate therapy parameters, the stimulation electrode located in proximity to the dorsal column of a patient; sensing, by a sensing electrode, an electrically evoked compound action potential (eECAP) signal in response to the delivery of the electrical stimulation; and classifying, by a processor, the sensed eECAP signal generated in response to the application of the candidate therapy relative to an eECAP baseline is disclosed.Type: GrantFiled: December 16, 2021Date of Patent: December 10, 2024Assignee: Medtronic, Inc.Inventors: David A. Dinsmoor, Timothy J. Denison, Xin Su
-
Patent number: 12161475Abstract: An implantable medical device includes a memory storing criteria for transitioning between states of a cardiac cycle model, the states including a P-wave state. The device also includes sensing circuitry that senses a cardiac signal that varies as a function of a cardiac cycle of a patient, and also includes processing circuitry coupled to the sensing circuitry. The processing circuitry is configured to detect an R-wave in the sensed cardiac signal, to determine an elapsed time since the detection of the R-wave, to determine one or more morphological values of a post-R-wave segment of the cardiac signal to compare the elapsed time and the one or more morphological values to the stored criteria for transitioning between the plurality of states of the cardiac cycle model, and to detect a P-wave in the sensed cardiac signal in response to a transition to the P-wave state of the cardiac cycle model.Type: GrantFiled: June 24, 2020Date of Patent: December 10, 2024Assignee: Medtronic, Inc.Inventors: Michael T. Hemming, Saul E. Greenhut
-
Patent number: 12161401Abstract: The present disclosure relates to devices, systems and methods providing evaluation and feedback to an operator of a device providing neuromodulation treatment, such as modulation of renal nerves of a human patient. In one embodiment, for example, a system monitors parameters or values generated before treatment. Feedback provided to an operator is based on the monitored values and relates to an assessment of various electrical properties associated with an electrode carried by a catheter. The electrode measures an electrical property of biological material making contact with the electrode while deploying the electrode, the electrical property being dependent on a ratio of a wall-interface area to a fluid-interface area.Type: GrantFiled: November 28, 2023Date of Patent: December 10, 2024Assignee: Medtronic Ireland Manufacturing Unlimited CompanyInventors: Vincent Ku, Sowmya Ballakur, Jignesh Shah
-
Patent number: 12161359Abstract: A catheter can restore the patency of a body lumen, for example, by removing tissue from a body lumen (e.g., a blood vessel). The catheter can be a rotational catheter having a rotatable drive shaft and a tissue-removing element secured to the drive shaft to be driven in rotation by the drive shaft. The catheter can have an abrasive burr configured to abrade tissue in a body lumen. The catheter can have an expandable tissue-removing element. The catheter can include a balloon and an inflation conduit. The catheter can also be configured to move over a guidewire through a body lumen. In one embodiment, the catheter comprises an over-the-wire, balloon-expandable, rotational, and abrasive tissue-removing catheter.Type: GrantFiled: May 19, 2022Date of Patent: December 10, 2024Assignee: Medtronic Vascular, Inc.Inventors: Mark Schneider, Ethan Andrew Guggenheimer, Nickolas Miller, Sengkham Sirivong, Bradley Steele, Babak Tabesh, Akshay Hulasare, Julie Bu
-
Patent number: D1054554Type: GrantFiled: August 5, 2022Date of Patent: December 17, 2024Assignee: Medtronic, Inc.Inventors: William J. Bertrand, Leanne M. Lintula, Leonard Porche
